Evidence map›Paper›PMID 34457265›Full record

ReviewAnnals of medicine and surgery (2012)2021

Coronavirus disease 2019 (COVID-19): Multisystem review of pathophysiology.

Tanveer Mir, Talal Almas, Jasmeet Kaur, Mohammed Faisaluddin, David Song, Waqas Ullah, Sahil Mamtani, Hiba Rauf, Sunita Yadav, Sharaad Latchana and 3 more

Open access · diamondAbstract readReview
In one paragraph

Review in Annals of medicine and surgery (2012), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Gastroesophageal reflux in lockdown.Future science OA · 2023
    Article
  7. Article
  8. Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Review
  9. Article
  10. Article
  11. Anti-PF4 antibodies associated with disease severity in COVID-19.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 12 institutions in 3 countries.

Tanveer MirInternal Medicine, Wayne State University, USA.
Talal AlmasRCSI University of Medicine and Health Sciences, Dublin, Ireland.
Jasmeet KaurInternal Medicine, Saint Joseph Mercy, Oakland Hospital, Pontiac, USA.
Mohammed FaisaluddinDepartment of Medicine, Rochester General Hospital, NY, USA.
David SongDepartment of Internal Medicine, Icahn School of Medicine at Mount Sinai Elmhurst Hospital, NY, USA.
Waqas UllahInternal Medicine, Abington Jefferson Health, PA, USA.
Sahil MamtaniAtlantiCare Medical Education, 2015 Pacific Avenue, Atlantic City, NJ, USA.
Hiba RaufDow Medical College, Karachi, Pakistan.
Sunita YadavNYC Health and Hospitals/Jacobi, The Bronx, NY, USA.
Sharaad LatchanaAmerican University of Integrative Sciences School of Medicine, Cole Bay, Sint Maarten.
Nara Miriam MichaelsonNeurology, New York Presbyterian/Weill Cornell Medical College, NY, USA.
Michael ConnerneyNeurology, University of California, Los Angeles, LA, USA.
Yasar SattarDivision of Cardiology, West Virginia University, Morgantown, USA.
American University of Integrative Sciences · SXAtlantiCare · USDow University of Health Sciences · PKElmhurst Hospital Center · USPresbyterian Hospital · USRochester General Hospital · USThe Bronx Defenders · USThomas Jefferson University Hospital · USTrinity Health Oakland Hospital · USUniversity of California, Los Angeles · USWayne State University · USWest Virginia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease-19 (COVID-19) pandemic is associated with high morbidity and mortality. COVID-19, which is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2), affects multiple organ systems through a myriad of mechanisms. Afflicted patients present with a vast constellation of symptoms, from asymptomatic disease to life-threatening complications. The most common manifestations pertain to mild pulmonary symptoms, which can progress to respiratory distress syndrome and venous thromboembolism. However, in patients with renal failure, life-threatening cardiac abnormalities can ensue. Various mechanisms such as viral entry through Angiotensin receptor (ACE) affecting multiple organs and thus releasing pro-inflammatory markers have been postulated. Nevertheless, the predictors of various presentations in the affected population remain elusive. An ameliorated understanding of the pathology and pathogenesis of the viral infection has led to the development of variable treatment options, with many more that are presently under trial. This review article discusses the pathogenesis of multiple organ involvement secondary to COVID-19 infection in infected patients.

Identifiers

PMID34457265
PMCPMC8381637
OpenAlexW3194676090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.